1. "Journal for ImmunoTherapy of Cancer"
Formats
  1. Meeting Abstract (237)
  2. Journal Article (120)
  3. Guidelines (18)
  4. Review (5)
  5. Editorial (1)
Groups
  1. Department of Medicine (327)
  2. Solid Tumor Oncology Division (298)
  3. Melanoma and Immunotherapeutics Service (125)
  4. GSK Faculty (117)
  5. Hematologic Malignancies, Division of (90)
  6. Sloan Kettering Institute Postdocs (85)

More Groups

People
  1. Jedd Wolchok (81)
  2. Taha Merghoub (55)
  3. Michael Postow (33)
  4. Matthew Hellmann (29)
  5. Roberta Zappasodi (24)
  6. Sadna Budhu (22)

More People

Years
  1. 2023 (21)
  2. 2022 (75)
  3. 2021 (57)
  4. 2020 (58)
  5. 2019 (34)
  6. 2018 (32)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (381)
Publishers
  1. Biomed Central Ltd (381)

Results (381)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
    Journal Article

    Alessi, J. V.; Price, A.; Richards, A. L.; Ricciuti, B.; Wang, X.; Elkrief, A.; Pecci, F.; Di Federico, A.; Gandhi, M. M.; Lebow, E. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Maron, S. B.; Cowzer, D.; King, S.; Schattner, M.; Janjigian, Y.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
    Guidelines

    Pavlick, A. C.; Ariyan, C. E.; Buchbinder, E. I.; Davar, D.; Gibney, G. T.; Hamid, O.; Hieken, T. J.; Izar, B.; Johnson, D. B.; Kulkarni, R. P.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
    Journal Article

    Molvi, Z.; Klatt, M. G.; Dao, T.; Urraca, J.; Scheinberg, D. A.; O'Reilly, R. J.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Journal Article

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
    Journal Article

    Tvingsholm, S. A.; Frej, M. S.; Rafa, V. M.; Hansen, U. K.; Ormhøj, M.; Tyron, A.; Jensen, A. W. P.; Kadivar, M.; Bentzen, A. K.; Munk, K. K.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
    Journal Article

    Florou, V.; Floudas, C. S.; Maoz, A.; Naqash, A. R.; Norton, C.; Tan, A. C.; Sokol, E. S.; Frampton, G.; Soares, H. P.; Puri, S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
    Guidelines

    Disis, M. L.; Adams, S. F.; Bajpai, J.; Butler, M. O.; Curiel, T.; Dodt, S. A.; Doherty, L.; Emens, L. A.; Friedman, C. F.; Gatti-Mays, M.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
    Journal Article

    Badran, Y. R.; Zou, F.; Durbin, S. M.; Dutra, B. E.; Abu-Sbeih, H.; Thomas, A. S.; Altan, M.; Thompson, J. A.; Qiao, W.; Leet, D. E.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save